mtor key modulator ageing age-related disease 
many experts biology ageing believe pharmacological interventions slow ageing matter rather leading target interventions nutrient response pathway defined mechanistic target rapamycin mtor inhibition pathway extends lifespan model organisms confers protection growing list age-related pathologies characterized inhibitors pathway already clinically approved others development although adverse side effects currently preclude use otherwise healthy individuals drugs target mtor pathway one day become widely used slow ageing reduce age-related pathologies humans 
